Revance Therapeutics Inc.

(RVNC) Trade

By |

Profile

Revance Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company's proprietary peptide technology enables the delivery of botulinum toxin type A through two investigational drug product candidates, DaxibotulinumtoxinA for Injection (RT002), or RT002 injectable, and DaxibotulinumtoxinA Topical Gel (RT001), or RT001 topical. The company is pursuing clinical development for RT002 injectable in a broad spectrum of aesthetic and therapeutic indications.

Contact Information

Website: www.revance.com
Email: jherbert@revance.com
Main Phone: +1 510 742-3400
Address: 7555 Gateway Boulevard
State: CA
City / Town: Newark
Country: US
Postal Code: 94560

Issuer Information

Exchange: NSD
CEO: Mark J. Foley
Employees: 193
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Revance Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company's proprietary peptide technology enables the delivery of botulinum toxin type A through two investigational drug product candidates, DaxibotulinumtoxinA for Injection (RT002), or RT002 injectable, and DaxibotulinumtoxinA Topical Gel (RT001), or RT001 topical. The company is pursuing clinical development for RT002 injectable in a broad spectrum of aesthetic and therapeutic indications.

Contact Information

Website: www.revance.com
Email: jherbert@revance.com
Main Phone: +1 510 742-3400
Address: 7555 Gateway Boulevard
State: CA
City / Town: Newark
Country: US
Postal Code: 94560

Issuer Information

Exchange: NSD
CEO: Mark J. Foley
Employees: 193
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 25.15 $ -0.14 (-0.55%)
Last Price 25.15 Change $ -0.14 Change % -0.55 Tick N/A
Bid 23.90 Bid Size 100.00 Ask 26.00 Ask Size 100.00
Open 25.24 High 25.25 Low 23.92 Prev Close 25.29
Last Trade Volume 476,802 52 Wk Hi 34.62 52 Wk Low 11.78
Market Cap 1.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 65,928,296.00 EPS (TTM) -4.23 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 23 57
Number of Buys 16 34
Number of Sells 7 23
Net Activity 66359 165621
Last 10 Buys Shares
Philip J. Vickers 1,000
Philip J. Vickers 1,000
Mark J. Foley 1,000
Mark J. Foley 1,000
Lauren P. Silvernail 1,000
Lauren P. Silvernail 1,000
L. Daniel Browne 1,000
Last 10 Sell Shares
Lauren P. Silvernail 1,000
Lauren P. Silvernail 1,000
Phyllis I. Gardner 1,000
L. Daniel Browne 1,000
L. Daniel Browne 1,000
Lauren P. Silvernail 1,000
Lauren P. Silvernail 1,000
L. Daniel Browne 1,000
Lauren P. Silvernail 1,000
L. Daniel Browne 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 58 58 58 58
Low Target Price Estimate 34 34 34 34
Mean Target Price Estimate 47.38 47.38 47.38 47.38
Standard Deviation 7.76 7.76 7.76 7.76
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 7
Moderate Buy 1 1 1 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.33 1.25